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Abstract
()-Epigallocatechin-3-gallate (EGCG) has been shown
to have potent antiphotocarcinogenic activity, but it
was required to develop a cream-based formulation for
topical application. For topical application, we tested
hydrophilic creamasa vehicle forEGCG.Treatmentwith
EGCG (c 1 mg/cm2 skin area) in hydrophilic cream
resulted in exceptionally high protection against photo-
carcinogenesis when determined in terms of tumor
incidence, tumor multiplicity, and tumor size in a SKH-1
hairless mouse model. EGCG also inhibited malignant
transformation of ultraviolet B (UVB)-induced papillo-
mas to carcinomas. In order to determine the mecha-
nism of prevention of photocarcinogenesis, we
determined the effect of EGCG on global DNA methyl-
ation pattern using monoclonal antibodies against
5-methyl cytosine and DNA methyltransferase in the
long-term UV–irradiated skin because altered DNA
methylation silencing is recognized as a molecular
hallmark of human cancer. We found that treatment
with EGCG resulted in significant inhibition of UVB-
induced global DNA hypomethylation pattern. Long-
term application of EGCG did not show any apparent
sign of toxicity inmicewhen determined in termsof skin
appearance, lean mass, total bone mineral content, and
total bone mineral density but showed reduction in fat
mass when analyzed using dual-energy X-ray absorpti-
ometry. These data suggest that hydrophilic cream
could be a suitable vehicle for topical application of
EGCG, and that EGCG is a promising candidate for
future cancer therapies based on its influence on the
epigenetic pathway.
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Introduction
The incidence of skin cancer among high-risk human popula-
tions is continuing to grow at an alarming rate, and approxi-
mately 1.3 million new cases of skin cancer, including basal
and squamous cell carcinomas, are diagnosed each year in the
United States [1]. Epidemiological, clinical, and biochemical
studies have implicated solar ultraviolet (UV) radiation, partic-
ularly UVB (290–320 nm) spectrum, as a complete carcinogen
and repeated exposures can lead to the development of
melanoma and nonmelanoma skin cancers [1–4]. The in-
creased risk of skin cancer is expected to continue as the
population ages and larger amounts of UV radiation reach the
surface of the Earth because of depletion of the ozone layer
[2–5]. Moreover, the increased tendency of individuals to
obtain a rapid tan and the use of tanning booths are also
implicated in the high risk of melanoma and nonmelanoma skin
cancers [1–5], the occurrence of which has a tremendous
impact on public health and healthcare expenditures. There-
fore, it is desired to develop newer and effective chemopre-
ventive agents and strategies, which can inhibit or slow down
the UV-induced risk of melanoma and nonmelanoma skin
cancers among high-risk human populations.
Cancer chemoprevention can prevent or delay the occur-
rence of cancer in high-risk human populations using dietary or
chemical intervention approaches. The worldwide interest is
considerably increasing in the use of naturally occurring bo-
tanical supplements, which can be used as cancer chemo-
preventive agents and/or as complementary and alternative
medicine. In earlier studies, polyphenols from green tea, a
widely consumed beverage worldwide, have been shown to
have anticarcinogenic activity in several in vitro and in vivo
models [6]. In earlier studies, it has been shown that topical
treatment of ()-epigallocatechin-3-gallate (EGCG), a poly-
phenolic constituent from green tea, in organic solvents such
Abbreviations: DXA, dual-energy X-ray absorptiometry; EGCG, ()-epigallocatechin-3-
gallate; TBMD, total bone mineral density; TBMC, total bone mineral content; UV, ultraviolet
Address all correspondence to: Santosh K. Katiyar, PhD, Department of Dermatology,
University of Alabama at Birmingham, 1670 University Boulevard, Volker Hall 557, Box 202,
Birmingham, AL 35294, USA. E-mail: skatiyar@uab.edu
1This work was supported, in part, by the National Cancer Institute (CA94593, CA89738), the
National Institute of Environmental Health Sciences (ES11421), and the Cancer Research and
Prevention Foundation (S.K.K.).
Received 10 September 2003; Revised 30 September 2003; Accepted 1 October 2003.
Copyright D 2003 Neoplasia Press, Inc. All rights reserved 1522-8002/03/$25.00
Neoplasia . Vol. 5, No. 6, November/December 2003, pp. 555–565 555
www.neoplasia.com
RESEARCH ARTICLE
as acetone onto the mouse skin inhibited 7,12-dimethylbenz[a]-
anthracene– initiated and 12-O-tetradecanoylphorbol-
13-acetate–promoted skin tumorigenesis [7], and also
inhibited UV-induced adverse biological effects associated
with skin carcinogenesis [8–11]. Use of organic solvents in
skin care products, or for topical treatment of pharmacologic
agents for human use, does not seem to be clinically
appropriate. Dvorakova et al. [12] have reported that topical
treatment of EGCG with hydrophilic cream achieved a high
concentration in the skin. Subsequently, very recently, we
tested the efficacy of EGCG in hydrophilic cream on SKH-1
hairless mouse skin against UVB-induced oxidative stress
and oxidative stress–mediated cell signaling pathways, such
as phosphorylation of mitogen-activated protein kinases
[13]. We found that treatment of EGCG in hydrophilic cream
resulted in exceptionally high protection against UVB-in-
duced oxidative stress and phosphorylation of mitogen-acti-
vated protein kinases [13]. The results from this in vivo study
encourage us to determine whether topical treatment with
EGCG in hydrophilic cream would provide exceptionally high
protection against UVB-induced skin tumorigenesis in
mouse models compared to previous observations, and the
suitability of this formulation for the safer use of EGCG
against UVB-induced adverse biological effects including
skin cancer.
In carcinogenesis, epigenetic alterations play a critical
role in the regulation of gene expression and are mediated
through modulation of heritable transcription superimposed
on the primary DNA sequence. Thus, without changing the
sequence of the DNA, epigenetic mechanisms such as DNA
methylation [e.g., 5-methylcytosine (5-mc) content of DNA]
can change the expression of proteins at transcriptional
levels [14]. Both hypermethylation and hypomethylation
can contribute to carcinogenesis by silencing of tumor sup-
pressor genes, upregulation of oncogenes, and/or de-
creased genomic stability [15,16]. Overall global DNA
hypomethylation and hypermethylation at GC-rich regions
are typical characteristics of tumors that could alter the
expression of genes [17]. Changes in methylation pattern
precede tumor formation, indicating that these alterations
might contribute to tumorigenesis [18]. The enzyme DNA
methyltransferase (DNMT) catalyzes the transfer of a methyl
moiety from S-adenosyl-L-methionine to cytosine principally
in the cytosine guanine dinucleotide [19,20]. Cancers with
aberrant methylation patterns have been observed to have
concurrent significant changes in their DNMT activities [21–
23]. There has been limited investigation on DNA methyla-
tion in mouse skin, but a few reports indicate methylation
differences between normal skin and tumor tissues [24,25].
As we believe, there have been no reported studies as yet on
the effect of UV irradiation on DNA methylation patterns in
murine skin, and chemopreventive effects of dietary constit-
uents such as EGCG on UVB-induced alterations in DNA
methylation pattern.
Therefore, the present study was designed to determine
the chemopreventive effect of topical application of EGCG in
hydrophilic cream (c 1 mg/cm2) on: 1) photocarcinogenesis
in terms of tumor incidence, tumor multiplicity, and tumor
growth; and 2) malignant transformation of benign papillo-
mas to carcinomas in SKH-1 hairless mouse models. We
also determined 3) whether prevention of photocarcinogen-
esis by EGCG is mediated by inhibition of UV-induced
changes in global DNA methylation pattern. Additionally,
for the first time, we also determined 4) the effect of long-
term topical treatment of EGCG on body composition such
as bone free soft lean tissue mass, fat mass, total bone
mineral content (TBMC), and total bone mineral density
(TBMD) using dual-energy X-ray absorptiometry (DXA) in
experimental animals.
Materials and Methods
Animals
Six- to seven-week-old female SKH-1 hairless mice,
which were obtained from Charles River Laboratories (Wil-
mington, MA), were used in this study. Mice were housed five
per cage and were acclimatized for at least 1 week before
use in animal facility and were maintained at standard
conditions of 12-hour light/12-hour dark cycle, 24 ± 2jC
temperature, and 50 ± 10% relative humidity. Animals were
fed Teklad Chow diet and water ad libitum. The animal
protocol for this study was approved by the Institutional
Animal Care and Use Committee of the University of Ala-
bama at Birmingham, in accordance with the current US
Department of Agriculture, Department of Health and Human
Service regulations and standards.
Chemicals and Antibodies
Diaminobenzidine substrate set and peroxidase-labeled
streptavidin were purchased from Kirkgaard and Perry (Gai-
thersburg, MD). 5-mc Ab was a gift from Dr. Alain Niveleau at
the University Joseph Fourier of Grenoble (Grenoble,
France). All chemicals employed in this study were of
analytical grade and purchased from Sigma Chemical Co.
(St. Louis, MO).
Preparation of EGCG Formulation in Hydrophilic Cream
Purified EGCG (> 98% pure) was procured from Tokyo
Food Techno Co. Ltd. (Shizuoka, Japan). EGCG was uni-
formly mixed in hydrophilic cream (Fougera and Co., Mel-
ville, NY) and was topically applied (c 1 mg/cm2 skin area)
onto the mouse skin 20 to 25 minutes before each UVB
exposure. This hydrophilic cream is prescribed for external
use as an ointment or cosmetic base. Formulation was
prepared on a weekly basis and stored at 4jC.
UVB Irradiation of Mice
UVB irradiation of mice was performed as described
previously [26,27]. Briefly, dorsal skin was exposed to UV
radiation from a band of four FS-20 fluorescent lamps from
which short wavelengths of UV (< 290 nm) not normally
present in natural solar light were filtered out using Kodacel
cellulose film (Eastman Kodak Co., Rochester, NY). The
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majority of the resulting wavelengths after Kodacel filtration
were in UVB (290–320 nm) and UVA range with peak
emission at 314 nm, as monitored. The UVB emission was
monitored before each UVB irradiation with an IL-1700
phototherapy radiometer equipped with an IL SED 240
detector fitted with a W side-angle quartz diffuser and a
SC5 280 filter (both from International Light, Newburyport,
MA). During UVB irradiation, mice were held in dividers
separated by Plexiglas.
Photocarcinogenesis Experiment and Protocol
At least 1 week after their arrival in the animal facility, the
mice were divided into different treatment groups with 20
mice in each group. Long-term photocarcinogenesis protocol
(including both UVB-induced tumor initiation and promotion
stages) was employed to determine the photoprotective
effect of EGCG as described previously [26,27]. Briefly, mice
were divided into two groups. Mice in group 1 were topically
treated with vehicle (hydrophilic cream) only, whereas group
2 was topically treated with EGCG in hydrophilic cream prior
to each UVB irradiation. Initially, mice in group 2 were
topically treated with EGCG for 14 days and, thereafter from
day 15, the mice belonging to both groups 1 and 2 were
irradiated everyday with UVB (180 mJ/cm2) and continued
for a total of 10 days. This period of UVB irradiation was
termed as tumor initiation stage. One week after the last UVB
exposure of tumor initiation, the mice were again UVB-
irradiated with the same dose (180 mJ/cm2) three times a
week to achieve tumor promotion stage.
During the experimental protocol, skin papillomas or
suspected carcinomas were observed and recorded weekly.
Tumors larger than 1 mm in diameter that persisted for
2 weeks or more were recorded. Tumor data were recorded
until their yield and size were stabilized. At this time point, the
dimensions of all the tumors on each mouse were recorded.
Tumor volumes were calculated by the hemiellipsoid model
formula: tumor volume = 1/2(4p/3)(1/2)(w/2)h, where l =
length, w = width, and h = height, as followed earlier
[26,27]. Carcinoma incidence and multiplicity were recorded
until 30 weeks of the experimental protocol. The diagnosis of
carcinoma was confirmed histologically either at the time
when carcinoma-bearing mice died, or at the termination of
the experiment at 30 weeks. Because of ulcerations and the
larger size of carcinomas, the Institutional Animal Care and
Use Committee at the University of Alabama at Birmingham
did not allow these experiments for a longer time; therefore,
experiments were stopped at this stage. At this time, carci-
noma incidence, multiplicity, and sizes were finally recorded.
Histology of the Skin
To evaluate the chemopreventive effect of topical treat-
ment of EGCG on long-term UVB irradiation-induced ad-
verse changes in skin morphology, mice were sacrificed at
the termination of the experiment at 30 weeks and dorsal
skin biopsies were collected, fixed in 10% buffered formalin,
and processed for H&E staining for microscopic evaluation.
Immunohistochemical Detection of DNA Methylation Pattern
Paraffin-embedded skin sections (6 mm thick) were
stained to detect DNA methylation patterns following antigen
retrieval methods, as described earlier with specific modifi-
cations [28]. Briefly, the sections were placed in 0.01mol/l citric
acid (pH 6.0) in a microwave oven set at full potency for 10
minutes. After antigen retrieval, the slides were immersed in
3.5 N HCl for 15 minutes at room temperature to expose the
CpG. The sections were then treated with 3% H2O2 for 5
minutes to quench endogenous peroxidase. Sections were
incubated with preimmune goat serum (3%) for 30 minutes
followed by incubation with 40 mg/ml AffiPure Fab (Jackson
Immunoresearch, Marseille, France) fragment goat anti–
mouse IgG (H + L) diluted in phosphate-buffered saline for
30 minutes to suppress nonspecific staining. The sections
were subsequently incubated with a hybridoma supernatant
containing anti–5-mc monoclonal antibody (7.5 mg/ml) for 1
hour. After washing the slides, sections were incubatedwith a
biotin–streptavidin detection system (Signet, Dedham, MA).
Companion matching slides processed identically and
stainedwithout primary antibody served as controls (deletes).
The substrate diaminobenzidene tetrahydrochloride was
used to detect the antigen–antibody complex, and sections
were counterstained with hematoxylin.
Assay for DNMT
Quantitative assay was performed to determine levels of
DNMT in skin tissues collected from different treatment
groups at the termination of the photocarcinogenesis exper-
iment. Age-matched normal (non-UV) skin was used as a
control. Details of the assay are described below.
Oligonucleotide DNA Substrates
Oligonucleotides for the DNMT assay were synthesized
as reported earlier [29]. Briefly, the sequence of 60-mer
oligonucleotide template was 5V-CATGGCCTAAGCAG-
GACTGAATGAGCAAGCTTCCGGAGAATTCTGCAG-
GACTGCAGATGC-3V containing one centrally located CpG
dinucleotide (underlined) in a HpaII/MspI recognition se-
quence (CCGG). For synthesis of the nonmethylated tem-
plate used for de novo methylation analysis, complementary
sequences were mixed at 500 ng/ml each, heated to 75jC for
10 minutes in 20 mM Tris–HCl (pH 7.5) and 50 mM NaCl,
and annealed by slow cooling to room temperature [29]. For
synthesis of the hemimethylated template to assess mainte-
nance methylation, 5-mc replaced the cytosine of the one
centralized CpG dinucleotide, and this oligonucleotide was
annealed with the nonmethylated complementary oligonu-
cleotide to create a hemimethylated CpG in the central
region of the oligonucleotide. All double-stranded oligonu-
cleotides were analyzed for annealing efficiency on 3%
(wt/vol) agarose gels and used only if the annealing process
was complete.
Determination of DNMT Activity
Tissue extracts were prepared by pooling together the skin
biopsies from at least four mice from each group, and
suspending them in approximately five times (wt/vol) that of
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the lysis buffer (10 mM Tris, pH 7.4, 150 mM NaCl, 1 mM
EDTA, 1 mM EGTA, 1 mM HEPES, 1% Triton X-100, 2 mg/
ml leupeptin, 2 mg/ml aprotinin, 2 mM sodium orthovanadate,
0.2 mM PMSF). This was followed by homogenization for
10-second bursts, up to a maximum of five times on ice.
The homogenate was centrifuged for 30 minutes at
12,000g at 4jC, and the supernatant was collected and
stored at 80jC for estimation of methyltransferase
enzymes, as described [30]. Briefly, the reaction mix of
30 ml—containing 5 mM H3-S-adenosyl-L-methionine (15 Ci/
mmol; NEN, Boston, MA), 1 mg of DNA substrate, and 18
ml of supernatant—was prepared and incubated for 2 hours
at 30jC. The reaction mixture was kept at 4jC to stop
further reaction. Now 30 ml of the sample was applied onto
Whatman (Whatman International, Maidstone, UK) GF/C
filters. The filters were then washed with graded concen-
tration of 50%, 20%, and 10% cold trichloroacetic acid. The
final rinse with absolute alcohol was done and the filters
were allowed to dry overnight at room temperature. The
next day, 3 ml of scintillation fluid was added to the filters
that had been taken in the scintillation vial in order to
quantify the units of radioactivity present in each sample by
using a liquid scintillation counter (LS 6500 multipurpose;
Beckman, Fullerton, CA). Enzyme activity was expressed
as counts per minute per microgram of protein. The 60-mer
oligonucleotide templates, either containing a centrally
located de novo methylation activity or a hemimethylated
CpG to measure maintenance DNMT activity, were used
as substrates in DNMT assays. Total protein content in the
samples was estimated using the DC protein assay kit
(BioRad, Hercules, CA). Units of activity were expressed
as counts per minute per microgram of protein.
Analysis of Cells Positive for 5-mc Staining
To determine the chemopreventive effect of EGCG on
UVB-induced global DNA methylation pattern, cells positive
for 5-mc in the epidermis were counted at random at six to
eight places in each section using an ocular micrometer
grid with  200 magnification under Zeiss Axiophot micro-
scope and Zeiss (Go¨ttingen, Germany) Plan-Neofluar ob-
jective. The ocular micrometer grid corresponds to 0.0625
mm2. After counting the number of 5-mc+ cells in three
sections per individual specimen, the number of 5-mc+ cells
in each treatment group was expressed as a percentage ±
SD of the mean count from at least three different animals
per group. The counting of 5-mc+ cells was performed
blindly by two independent observers.
Evaluation of Nontoxicity of EGCG in Hydrophilic Cream:
In Vivo Analyses of TBMD, TBMC, Lean Mass, and Fat
Mass in Mice by DXA
We were interested to assess the long-term effect of the
topical application of EGCG in hydrophilic cream on mice;
therefore, we determined some physico-chemical parame-
ters such as bone free soft lean tissue mass, TBMD, TBMC,
and fats in mice of different treatment groups using the DXA
analysis technique, as described earlier [31]. These param-
eters were analyzed at the end of the 30th week of photo-
carcinogenesis experiment. For this purpose, mice were
sacrificed and kept at 80jC until they were analyzed. The
head part of the mouse was not included in any of these
measures, and DXA analysis was performed on thawed
animals.
Statistical analysis
In tumorigenesis experiments, the statistical significance
of differences between the UVB-alone and EGCG + UVB
treatment groups in terms of tumor incidence and tumor
multiplicity was evaluated by chi-square analysis and Wil-
coxon rank sum test, respectively. An advantage of Wilcoxon
rank sum test is that its validity does not depend on any
assumption about the shape of the distribution of tumor
multiplicities. Kinetics of tumor multiplicity was analyzed by
using the Fisher-Irwin exact test. Student’s t-test was used to
determine the statistical significance of differences in tumor
volume, fat content, percent cells positive for 5-mc (global
DNA methylation+), and DNMT data analysis between UVB-
alone and EGCG + UVB–treated groups.
Results
Topical Application of EGCG in Hydrophilic Cream Affords
Exceptionally High Protection of Photocarcinogenesis
Our prior study indicated that topical application of EGCG
in hydrophilic cream significantly inhibited UVB-induced ox-
idative stress and phosphorylation of MAPK proteins in in
vivo mouse skin [13]. Prevention by EGCG treatment in this
formulation was greater than that of previous reports
(reviewed in Ref. [8]). Because UVB-induced oxidative
stress and activation of MAPK pathway play an important
role in UV carcinogenesis, we performed studies to deter-
mine whether the degree of prevention of photocarcinogen-
esis by EGCG in this formulation is greater than that of
previous observations (reviewed in Refs. [6,8]). Following
complete photocarcinogenesis protocol (UVB-induced both
initiation and promotion) in SKH-1 hairless mouse models,
topical application with EGCG resulted in a significant re-
duction in UV-induced tumorigenesis when expressed in
terms of tumor incidence (Figure 1, Panel A) and tumor
multiplicity (Figure 1, Panel B) compared to that of non–
EGCG-treated but UVB-irradiated control animals. Treat-
ment of EGCG resulted in 60% (P < .001) inhibition of tumor
incidence (percent of mice with tumors) at the termination of
the experiment at 24 weeks as compared to non–EGCG-
treated mice (Figure 1, Panel A). Non–EGCG-treated ani-
mals achieved 100% tumor incidence on the 16th week of
tumor promotion, whereas EGCG-treated mice could not
achieve 100% tumor incidence up to the end of the 24th
week when the tumor incidence was stabilized. Furthermore,
treatment of EGCG increased the latency period of tumors
by 7 weeks during the 24-week-long tumor protocol. In this
photocarcinogenesis protocol, a total of 360 tumors (18 ± 2.5
tumors/tumor-bearing animal) was recorded in UVB-alone–
irradiated (non-EGCG) group of mice, whereas only 48
tumors (6 ± 0.5 tumors/tumor-bearing mouse) were recorded
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with treatment of EGCG (Figure 1, Panel B). Each group
contained 20 mice. Thus, topical treatment of EGCG in
hydrophilic cream resulted in significant inhibition of UV-
induced tumor multiplicity (86%, P < .001) compared to that
of UVB-alone-irradiated control group (Figure 1, Panel B
and Table 1). Furthermore, the rate of tumor appearance
and their development in EGCG-treated animals were sig-
nificantly decreased (P < .01, Fisher-Irwin exact test)
throughout the experimental protocol compared to the non–
EGCG-treated control group. As summarized in Table 1, the
growth or size of tumors in the EGCG-treated group was also
significantly inhibited when measured in terms of total tumor
volume/group, tumor volume/tumor-bearing mouse, and av-
erage tumor volume/tumor, respectively by 95% (P < .001),
65% (P < .001), and 62% (P < .001) compared to that of
the non–EGCG-treated group. The treatment of hydrophilic
cream alone onto the mouse skin for 30 weeks did not in-
duce tumor formation (data not shown).
Prevention of Malignant Transformation of Papillomas
to Carcinomas
After observing that topical application of EGCG signif-
icantly inhibited UVB radiation– induced skin tumorigene-
sis, we continued to look at the chemopreventive efficacy
of EGCG on malignant transformation of benign papillomas
to carcinomas. Therefore, this experiment was extended
up to 30 weeks. Histological observations indicated that
papillomas have started transforming into carcinomas at
the 23rd week of UVB-induced tumor promotion stage. As
shown in Figure 2, 80% of mice developed carcinoma in
the non–EGCG-treated group compared with that of only
20% mice with carcinomas in the EGCG-treated group.
Thus, 60% (P < .001) prevention was observed in terms
of carcinoma incidence by topical application of EGCG
(Figure 2, Panel A). The weekly progression of carcinoma
multiplicity in terms of total number of carcinomas per
group and number of carcinomas per carcinoma-bearing
mouse was recorded as shown in Panels B and C,
respectively (Figure 2). Analysis of data indicated that 18
papillomas were transformed into carcinomas in the non–
EGCG-treated but UVB-irradiated group of mice, whereas
only four papillomas were transformed into carcinomas in
the EGCG + UVB–treated group. These data indicated
that topical application of EGCG resulted in 78% (P < .001)
prevention of UVB-induced transformation of benign papil-
lomas to carcinomas (Table 2). When data were analyzed
in terms of number of carcinomas per carcinoma-bearing
mouse, the protective effect of EGCG was not significant
compared to that of the non–EGCG-treated (UVB-alone)
group. Furthermore, topical application of EGCG inhibited
the growth of carcinoma. As evidenced by the analysis of
physical characteristics of carcinomas (Table 2), topical
application with EGCG to UVB-irradiated mice resulted in
significant inhibition in terms of total carcinoma volume/
group and average carcinoma volume/carcinoma by 88%
and 87% (P < .001), respectively, compared to that of the
non–EGCG-treated group of mice.
Figure 1. Chemopreventive effects of topical application of EGCG (1 mg/
cm2) in hydrophilic cream on UVB-induced skin tumorigenesis in SKH-1
hairless mice. The details of the experimental protocols are described in
Materials and Methods section. The percent of mice with tumors (Panel A)
and the number of tumors per tumor-bearing mouse (Panel B) were plotted as
a function of the number of weeks of treatment. Each treatment group
contained 20 mice, and tumor data were recorded until the 24th week of UVB-
induced tumor promotion when tumor yield was stabilized. The number of
tumors per tumor-bearing mouse has been shown as mean ± SD.
Table 1. Protective Effect of Topical Application of EGCG in Hydrophilic
Cream on UVB-Induced Tumors in Mice.
Physical Characteristics* Treatment Groupsy % Inhibition
UVB alone EGCG +
UVB
Total number of tumors/
group
360 48 86z
Total tumor volume/
group
9230 490 95z
Tumor volume/ tumor-
bearing mouse
462 ± 44§ 162 ± 10 65z
Average tumor volume/
tumor (mm3)
26 10 62z
*Total number of tumors and tumor volume in different treatment groups were
recorded at the end of 24 weeks when tumor yield and size were stabilized.
yDetails of treatment groups are provided in Materials and Methods section.
EGCG was administered topically (1 mg/cm2 skin area), 20 to 25 minutes
prior to each UVB irradiation.
zHighly significant versus UVB alone ( P < .001).
§Mean ± SD obtained from 20 animals in each group at the time of data
recording.
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Topical Application of EGCG in Hydrophilic Cream Prevents
UVB-Induced Adverse Morphological Changes in the Skin
Chronic exposure of mouse skin to UV radiation induced
morphological changes, which make skin susceptible to
various skin disorders [5]. As shown in Figure 3, long-term
exposure of the skin to UVB for 30 weeks induced markers of
inflammatory responses, such as infiltration of inflammatory
leukocytes, edema development, and hyperplastic response
(increased number of epidermal cell layers) compared to that
of non–UVB-exposed skin. UV-induced infiltrating leuko-
cytes are the major source of oxidative stress [32], and thus
a contributing factor in skin carcinogenesis. Treatment of
EGCG markedly inhibited UVB-induced edema (bifold skin
thickness), hyperplastic response, and leukocyte infiltration
(Figure 3, Panel C) compared to that of non–EGCG-treated
but UVB-irradiated skin, as can be seen in Figure 3 (Panel
B). Thus, it can be suggested that inhibition of UVB-induced
leukocyte infiltration could inhibit oxidative stress and thus
could be responsible for the prevention of adverse biological
effects of UVB radiation.
Topical Application of EGCG in Hydrophilic Cream Prevents
UVB-Induced Global DNA Hypomethylation
In order to determine the mechanism of protection of
photocarcinogenesis by topical application of EGCG in the
mouse skin, we performed experiments to detect whether
topical application with EGCG affects UVB-induced altera-
tions in global DNA methylation pattern. For the first time, we
showed the effect of chronic UV exposure on DNA methyl-
ation pattern using immunohistochemical detection tech-
nique. We observed that chronic exposure of UV radiation
at the end of the photocarcinogenesis protocol (at the 30th
week) resulted in global DNA hypomethylation (Figure 4,
Panel B) when compared with that of age-matched non-
UVB-exposed skin (Figure 4, Panel A). UV-induced hypo-
methylation or hypermethylation patterns of DNA have been
implicated in carcinogenesis [33]. This is the first observation
or report which identified that chronic UVB irradiation
resulted in the hypomethylation pattern of DNA (5-methyl
cytosine–specific) in mouse skin (Figure 4). Non–UVB-
exposed skin showed cells positive for 5-mc. The antibody
specific to 5-mc is not specific to a particular cell type.
Topical application of EGCG throughout the experimental
protocol for 30 weeks prior to each UVB irradiation resulted
in inhibition of UVB-induced global DNA hypomethylation
(Figure 4, Panel C). Cells positive to 5-mc were counted in
the epidermis at random at six to eight sites in each section of
different treatment group under a microscope. We counted
the percentage of cells positive to 5-mc (n = 3) in theFigure 2. Chemopreventive effects of topical application of EGCG (1 mg/
cm2) in hydrophilic cream on UVB-induced malignant transformation of
papillomas to carcinomas during UVB-induced skin tumorigenesis protocol in
SKH-1 hairless mice. The details of the experiment are described in Materials
and Methods section. The percent of mice with carcinomas (Panel A), the
number of carcinomas per group (Panel B), and the number of carcinomas
per carcinoma-bearing mouse (Panel C) were plotted as a function of the
number of weeks of treatment. Each treatment group contained 20 mice, and
the number of carcinoma/carcinoma-bearing mouse has been shown as
mean ± SD.
Table 2. Protective Effect of Topical Application of EGCG in Hydrophilic
Cream on UVB-Induced Carcinomas at the Termination of the Photocarcino-
genesis Protocol in Mice.
Physical Characteristics* Treatment Groups % Inhibition
UVB
alone
EGCG +
UVB
Total number of carcinomas/
group
18 4 78y
Total carcinoma volume/
group (mm3)
8010 950 88y
Carcinoma volume/carcinoma-
bearing mouse (mm3)
501 ± 25z 238 ± 12 53§
Average carcinoma volume/
carcinoma (mm3)
445 ± 29 60 ± 1 87y
*Total number of carcinoma and carcinoma volume were recorded at the
termination of the experiment at 30 weeks when carcinoma yield and size
were stabilized.
yHighly significant versus UVB alone ( P < .001).
zMean ± SD were obtained from 20 animals in each group at the time of data
recording.
§Significant versus UVB alone ( P < .01).
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Figure 3. Topical application of EGCG in hydrophilic cream inhibits UVB-
induced adverse biochemical changes in the skin of SKH-1 hairless mice.
H&E staining was performed on skin tissue sections to observe the changes
as detailed in Materials and Methods section. Panel A: Normal skin (non–
UVB-irradiated). Panel B: UVB-alone– irradiated skin showing hyperplastic
response and spongiosis (edematous) in epidermis and dermis, and larger
number of infiltrating leukocytes compared to normal skin. Leukocytes are
shown by black nuclei. Panel C: UVB-irradiated skin pretreated with EGCG.
Treatment of EGCG inhibits UVB-induced hyperplastic response and
spongiosis in the epidermis and dermis, and lesser number of infiltrating
leukocytes compared to UVB alone. Magnification,  10.
Figure 4. Topical treatment of EGCG in hydrophilic cream inhibits UVB-
induced global DNA hypomethylation pattern in chronically UVB-exposed
mouse skin for 30 weeks. Immunohistochemical detection of DNA methyl-
ation pattern was performed using anti –5-mc monoclonal antibody as
detailed in Materials and Methods section. Panel A: Normal skin (non–UVB-
exposed). Panel B: UVB irradiation alone. Panel C: EGCG + UVB– irradiated
skin. Skin biopsies were subjected to staining for DNA methylation using
antibody specific to 5-mc. Cells positive for 5-mc staining appears brown in
color. Normal skin showed the presence of numerous positive cells in the
epidermis (Panel A) whereas chronic exposure of UVB radiation induced
global DNA hypomethylation pattern in the skin (Panel B). Pretreatment with
EGCG prevented chronic UVB irradiation– induced global DNA hypomethy-
lation in the skin (Panel C). Magnification,  40. Panel D: The percentage of
cells positive for 5-mc in the epidermis was plotted against different treatment
groups as mean ± SD from four animals in each group.
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epidermis, which were approximately 83 ± 10%, 5 ± 2% ,and
62% ± 10%, respectively, in normal (non-UVB), UVB-alone,
and EGCG + UVB–irradiated skin (Figure 4, Panel D). Thus,
topical treatment of EGCG inhibited UVB-induced global
DNA hypomethylation pattern by 69% (P < .001) when
determined in terms of 5-mc+ cells. These data indicated
that topical application of EGCG abrogated UVB-induced
global DNA hypomethylation, thus suggesting a possible
mechanism of prevention of photocarcinogenesis in this
mouse model.
Topical Application of EGCG in Hydrophilic Cream Main-
tains DNMT in UVB-Exposed Skin
After observing the abrogating effect of EGCG on UVB-
induced global DNA hypomethylation in the skin of mice, it
was imperative to determine the levels of DNA methyltrans-
ferase enzymes, which are responsible for maintaining the
methylation status of the DNA. At the termination of the
photocarcinogenesis experiment at 30 weeks, skin homoge-
nates were assayed for DNMT activities. The normal skin
showed constitutive activity of 79 ± 7 cpm/mg protein DNMT1
enzyme (Table 3)—the enzyme responsible for maintaining
the hemimethylation status of the DNA after replication. In
the UVB-irradiated skin, the activity of DNMT1 dropped by
41% (P < .01) as compared to that of normal skin. Treatment
with EGCG had significantly attenuated UVB-induced deple-
tion of DNMT activity by 57% (P < .01) as compared to that of
non–EGCG-treated but chronic UVB-irradiated skin. The
assays of DNMT3a and DNMT3b activities, which are re-
sponsible for the de novo methylation in the cell resulting in
aberrant methylation at unmethylated sites, revealed that on
chronic UVB irradiation, the activity had been upregulated by
26% (78.8 ± 7, P < .05) as compared to the normal (non-
UVB) skin (62.8 ± 6) (Table 3). But on EGCG treatment,
UVB-induced changes in the de novo methyltransferase
activity had been reduced nearly to 54.8 ± 5 cpm/mg protein.
The ratio of the maintenance methyltransferase activity to
the de novo methyltransferase activity plays a crucial role in
the maintenance of DNA methylation pattern [33,34]. The
ratio of these enzymes in the normal skin was found to be
1.26. It was observed that chronic UVB irradiation resulted in
a significantly low ratio (0.59, P < .05) as compared to that of
normal (non-UV) skin. Continuous treatment with EGCG on
UVB-irradiated mice resulted in an approximately normalized
ratio of maintenance and de novo methyltransferase activi-
ties (1.2) as compared to that of the control group of mice.
Long-Term Application of EGCG in Hydrophilic Cream Has
No Apparent Toxicity to Skin, TBMC, and TBMD
But Decreases Fat Content
To determine whether long-term use of EGCG in hy-
drophilic cream has any apparent toxic effect in animals,
animals were subjected to assessment of skin appearance
by blind observers, and they assessed the effects on lean
mass (bone-free tissue mass), fat mass, TBMC, and
TBMD, and compared them with non–EGCG-treated ani-
mals as well as UVB-alone–irradiated animals. As ob-
served by three independent observers, the visual skin
appearance of animals treated with EGCG was better than
that of non–EGCG-treated animals. DXA analysis revealed
that there was no significant difference in TBMD, TBMC,
and lean mass in EGCG-treated (EGCG + UVB) animals
compared with that of non–EGCG-treated (UVB-alone and
control) mice (Table 4). Intriguingly, long-term topical ap-
plication with EGCG resulted in a significant reduction in
total tissue fat content (21–25%, P < .05) compared to that
of non–EGCG-treated animals. Analysis was performed at
the end of the experiment. Head was not included in this
body composition analysis by DXA [31]. Body composition
data suggested that reduction in fat mass could also have
a role, at least in part, in the prevention of UV carcinogen-
esis by EGCG in this animal model.
Discussion
The present study is an extension of our recent published
report wherein we have shown that topical application of
EGCG in hydrophilic cream afforded exceptionally high
protection against UVB-induced oxidative stress and phos-
phorylation of MAPK proteins, which play an important role in
cellular differentiation, proliferation, and leads to carcinogen-
esis [13]. In the present study, topical application of EGCG in
hydrophilic cream resulted in exceptionally high protection
against photocarcinogenesis in SKH-1 hairless mouse mod-
els. Photocarcinogenesis was assessed in terms of tumor
incidence and tumor multiplicity (on a weekly basis) and
tumor size, which was measured at the termination of the
experiment (Figure 1 and Table 1). We tried to develop a
cream-based formulation for the topical treatment of EGCG
for future human use, and the data obtained in this experi-
ment revealed that the chemopreventive effect of EGCGwas
superior to all earlier studies where mostly organic solvent
Table 3. Protective Effect of Topical Application of EGCG in Hydrophilic
Cream on the DNA Methyltransferase Activity at the Termination of the
Photocarcinogenesis Protocol*.
Treatment Groupsy Maintenance
Methylationz (cpm/g protein)
De Novo Methylation§
(cpm/g protein)
Normal 79.1 ± 7 62.8 ± 6
UVB alone 46.5 ± 4b 78.8 ± 7b
EGCG +
UVB
65.2 ± 6b,# 54.8 ± 5b
*The skin lysates were pooled from four mice from each treatment group at
the termination of the experiment, and methyltransferase activity was
analyzed in triplicate.
yThe details of the experiment are described in Materials and Methods
section. EGCG was administered topically (1 mg/cm2), 20 to 25 minutes prior
to each UVB irradiation.
zMaintenance methylation (DNMT1) was assessed in triplicate using a 60-
mer double-stranded oligonucleotide containing one centralized hemimethy-
lated CpG. Counts-per-minute values represent the amount of radioactivity
transferred by the enzyme from titrated S-adenosyl-L-methionine to the
double-stranded template in 2 hours. Values are presented as mean ± SEM.
§De novo methylation (DNMT3) was assessed in triplicate as for main-
tenance methylation except using a 60-mer oligonucleotide containing one
centralized CpG with no preexisting methylation in the template. Values are
presented as mean ± SEM.
bSignificant difference versus UVB alone ( P < .05).
#Significant difference versus UVB-induced depletion of maintenance
methylation, ( P < .01).
562 Exceptionally High Antiphotocarcinogenic Activity of EGCG Mittal et al.
Neoplasia . Vol. 5, No. 6, 2003
acetone was used as a vehicle for the administration of
EGCG [6,8,32,35]. It may be because of the fact that the
use of hydrophilic cream enhanced the penetrating ability of
EGCG in the skin [12]. With respect to the nature of UV
radiation, it is worth mentioning that UV radiation has both
tumor-initiating and tumor-promoting activities as it causes
"signature" mutations at the genomic level as well as epige-
netic changes. Therefore, it is not possible to design a clean
UVB-induced initiating and/or promoting protocol; however,
to study the causes, mechanisms, and preventive
approaches of UV carcinogenesis, multistage photocarcino-
genesis protocols are generally employed [5,26,27]. Earlier,
we have reported that treatment of EGCG inhibited UV
irradiation– induced oxidative stress in both animal and
human skin [32,36], and that oxidative stress plays a crucial
role in tumor promotion as well as in tumor initiation. Thus,
the prevention of oxidative stress by EGCG could be a
possible mechanism of prevention of photocarcinogenesis.
Moreover, chronic inflammation is also considered a bio-
marker of tumor promotion [5], chronic UV irradiation– in-
duced hyperplastic response, and infiltration of inflammatory
leukocytes in the skin (Figure 3, Panel B). Prevention of
these events by EGCG would decrease the risk of UV
carcinogenesis (Figure 3, Panel C).
The present study provides additional new information
that topical application of EGCG inhibits malignant transfor-
mation of benign papillomas to carcinomas (Figure 2 and
Table 2). Transformation of benign papilloma to carcinoma
requires further genetic and epigenetic changes in the tumor
cells and this can be achieved by using free radical–gener-
ating agents [37,38] or genotoxic substances [39]. It
appeared that chronic exposure of UVB radiation performed
these alterations/functions. The increase in the rate of ma-
lignant transformation by free radical–generating agents
may be related to free radical–mediated enhancement of
genetic instability [40]. Therefore, the results of this study
suggest that EGCG might have inhibited carcinoma inci-
dence and multiplicity by inhibiting UVB-induced free radical
generation and therefore free radical–mediated enhance-
ment of genetic instability. It has been documented that
transformation of benign papillomas to carcinomas requires
further genetic changes in papillomas, which can be
achieved by tumor-initiating agents [39,41]. In the present
photocarcinogenesis protocol, repeated exposure of UVB to
papillomas would result in further genetic changes in tumor
cells [5], which would enhance the malignant conversion of
benign papillomas to carcinomas. Therefore, it can be sug-
gested that EGCG affords protection against genetic and
epigenetic alterations caused by chronic UVB irradiation. It is
important to mention that EGCG shows a UV absorption
peak at or near 270 to 273 nm, and therefore, it is likely that
EGCG could block some short wavelengths (< 290 nm) of
UVB spectra. Similar chemopreventive observations were
also reported when topical treatment of green tea polyphe-
nols (mixture of polyphenols from green tea) inhibited ben-
zoyl peroxide–induced (free radical–generating agent) and
4-nitroquinoline-N-oxide– induced (initiating agent) malig-
nant transformations of chemically induced papillomas into
carcinomas [42].
Cancer is a manifestation of both abnormal genetic and
epigenetic events. The importance of epigenetic events is
that it represents a mechanism by which gene function is
selectively activated or inactivated. Because epigenetic
events are susceptible to change, they represent excellent
targets to explain how environmental factors, including die-
tary constituents/supplements/chemopreventive agents,
may modify cancer risk and tumor behavior. DNA methyla-
tion is such a marker of epigenetic events, and is a funda-
mental process that not only modulates gene expression, but
is also key to regulating chromosomal stability [33,34].
Abnormal DNA methylation, both hypermethylation and
hypomethylation patterns, is a hallmark of most cancers,
including colon, lung, prostate, and breast cancers, and can
contribute to carcinogenesis by silencing of tumor suppres-
sor genes, upregulation of oncogenes, and/or decreased
genomic stability [15,16,33,34]. Changes in methylation pat-
tern precede tumor formation, indicating that these altera-
tions might contribute to tumorigenesis [18,33,34]. In view of
these facts, we studied the pattern of global DNAmethylation
in chronically UV exposed skin, which may have a role in skin
cancer, and also determined the effect of nutrients such as
EGCG on this epigenetic marker. We observed that chron-
ically UV-exposed skin for 30 weeks shows global DNA
hypomethylation pattern and lowering of maintenance meth-
ylation in the mouse skin (Figure 4 and Table 3). Treatment
of EGCG prior to each UV exposure resulted in a significant
inhibition of UV-induced global DNA hypomethylation and
reversed the effect on DNMT activities in chronically UV-
exposed skin (Figure 4 and Table 3). Because methylation
changes are reversible, they may also lead to the develop-
ment of novel therapeutic strategies to reverse or inhibit the
transformed phenotype through the use of known or novel
chemopreventive agents, such as EGCG, to correct aberrant
methylation patterns and restore growth control in tumor
cells and/or against the adverse effects of solar UV radiation.
The exact mechanism of altered DNA methylation pattern by
EGCG is not known at this stage; however, it can be
Table 4. Effect of Topical Application of EGCG in Hydrophilic Cream on
Bone Mineral Density, Bone Mineral Content, Lean Mass and Fat in Mice*.
Treatment Group TBMD
(mg/cm2)
TBMC
(mg)
Lean
(g)
Fat
(g)
Control
(non-EGCG)
65 ± 4y 582 ± 13 19.9 ± 1.9 5.3 ± 1.3
EGCG alone 61 ± 2 561 ± 33 20.3 ± 1.7 4.2 ± 0.8(21)z
UVB alone 57 ± 4 539 ± 57 20.4 ± 2.4 5.3 ± 1.2
EGCG + UVB 60 ± 3 542 ± 47 20.9 ± 1.4 4.0 ± 0.9(25)§
The values in parentheses indicate percent reduction in fat content by EGCG
treatment.
*Photocarcinogenesis experiment was continued for 30 weeks. At the end of
the experiment, mice were sacrificed and subjected to DXA analysis. A brief
description of analysis is described in Materials and Methods section. Each
treatment group contained 20 mice. TBMD = total bone mineral density (bone
mineral content/bone area); TBMC = total bone mineral content.
yData are expressed as mean ± SD from 20 animals in each group.
zSignificant reduction in fat content, EGCG alone versus non-EGCG
treatment ( P < .05).
§Significant reduction in fat content, EGCG+UVB versusUVB alone ( P < .05).
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assumed that EGCG may influence the supply of methyl
groups for the formation of S-adenosylmethionine, and/or
modify utilization of methyl groups by processes including
shifts in DNMT activity. However, more studies on this
aspect are required to give appropriate answers on these
questions.
Lastly, we were interested to determine the adverse effect
of long-term topical treatment of EGCG with this formulation
on the skin, if any. Mice were administered topically applied
EGCG in hydrophilic cream for 30 weeks, and at the termi-
nation of the experiment, it was found that EGCG has no
adverse apparent visual toxic effect on the skin. The suit-
ability of EGCG in cream was also determined by assessing
various physico-chemical parameters in EGCG-treated ani-
mals and compared with that of non–EGCG-treated ani-
mals. It was observed that during the period of 30 weeks,
animals neither lost nor gained body weight (data not
shown), which may have distorted their physical or metabolic
activity. Most importantly, long-term treatment with EGCG
did not affect lean mass, TBMD, and TBMC when analyzed
in vivo by DXA (Table 4). These observations provide ample
evidence for the first time that topical treatment of EGCG has
no apparent toxic effects in animals. The most significant
observation is that treatment of EGCG decreased total fat
mass in animals, which may have a relationship with the
inhibition of UV-induced tumor incidence, multiplicity, and
transformation of papillomas to carcinomas. Although sev-
eral dietary modifications are known to inhibit carcinogene-
sis, and some may decrease body fat levels in rodents (e.g.,
caloric restriction) [43–45], this study provides evidence that
inhibition of photocarcinogenesis by EGCG has a relation-
ship with the reduction of tissue fat levels. This may be
attributed to the fact that EGCG increased lipolysis or
decreased the synthesis of fat without changing the body
mass. It may be of interest to determine the effects of EGCG
on the profile of fatty acids in epidermal phospholipids and in
the neutral fats of parametrial fat pads. EGCG-induced
decrease in arachidonic acid level in fat could result in
decreased levels of prostaglandin metabolites that are be-
lieved to play a role in skin carcinogenesis [5].
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